Journal
BIOTECH
Volume 11, Issue 3, Pages -Publisher
MDPI
DOI: 10.3390/biotech11030023
Keywords
cardiovascular diseases; translational medicine; digital health
Categories
Funding
- Instituto de Salud Carlos III [PI16/01123, DTS16/0160, PI17/01059, PI19/00161, PI20/01618, DTS21/00064, PI18/01895, Red TERCEL RETIC RD16/0011/0029, RICORS RD21/0017, 002]
- Regional Government of Madrid [S2017/BMD-3962]
- Spanish Ministry of Science and Innovation (CIBERCV)
- European Union [874827 (BRAV3)]
Ask authors/readers for more resources
Translational science plays a crucial role in connecting basic and clinical levels in the field of cardiovascular diseases, aiming to transfer potential treatments from preclinical stages to clinical practice. The introduction of digital health solutions has enhanced this transfer process.
Translational science has been introduced as the nexus among the scientific and the clinical field, which allows researchers to provide and demonstrate that the evidence-based research can connect the gaps present between basic and clinical levels. This type of research has played a major role in the field of cardiovascular diseases, where the main objective has been to identify and transfer potential treatments identified at preclinical stages into clinical practice. This transfer has been enhanced by the intromission of digital health solutions into both basic research and clinical scenarios. This review aimed to identify and summarize the most important translational advances in the last years in the cardiovascular field together with the potential challenges that still remain in basic research, clinical scenarios, and regulatory agencies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available